152 related articles for article (PubMed ID: 12801948)
1. Mortality study of 18 000 patients treated with omeprazole.
Bateman DN; Colin-Jones D; Hartz S; Langman M; Logan RF; Mant J; Murphy M; Paterson KR; Rowsell R; Thomas S; Vessey M;
Gut; 2003 Jul; 52(7):942-6. PubMed ID: 12801948
[TBL] [Abstract][Full Text] [Related]
2. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.
García Rodríguez LA; Lagergren J; Lindblad M
Gut; 2006 Nov; 55(11):1538-44. PubMed ID: 16785284
[TBL] [Abstract][Full Text] [Related]
3. Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus.
Wani S; Sampliner RE; Weston AP; Mathur S; Hall M; Higbee A; Sharma P
Aliment Pharmacol Ther; 2005 Oct; 22(7):627-33. PubMed ID: 16181302
[TBL] [Abstract][Full Text] [Related]
4. Acid suppression in the long-term treatment of peptic stricture and Barrett's oesophagus.
Lundell L
Digestion; 1992; 51 Suppl 1():49-58. PubMed ID: 1356869
[TBL] [Abstract][Full Text] [Related]
5. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
Drugs; 2002; 62(7):1091-118. PubMed ID: 11985491
[TBL] [Abstract][Full Text] [Related]
6. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus.
Todd JA; Basu KK; de Caestecker JS
Aliment Pharmacol Ther; 2005 Apr; 21(8):969-75. PubMed ID: 15813832
[TBL] [Abstract][Full Text] [Related]
7. Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus.
Marshall RE; Anggiansah A; Manifold DK; Owen WA; Owen WJ
Gut; 1998 Nov; 43(5):603-6. PubMed ID: 9824338
[TBL] [Abstract][Full Text] [Related]
8. Effects of omeprazole or anti-reflux surgery on lower oesophageal sphincter characteristics and oesophageal acid exposure over 10 years.
Emken BG; Lundell LR; Wallin L; Myrvold HE; Engström C; Montgomery M; Malm AR; Lind T; Hatlebakk JG;
Scand J Gastroenterol; 2017 Jan; 52(1):11-17. PubMed ID: 27593706
[TBL] [Abstract][Full Text] [Related]
9. Gastric polyps and nodules in children receiving long-term omeprazole therapy.
Pashankar DS; Israel DM
J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):658-62. PubMed ID: 12454582
[TBL] [Abstract][Full Text] [Related]
10. Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa.
Lamberts R; Brunner G; Solcia E
Digestion; 2001; 64(4):205-13. PubMed ID: 11842276
[TBL] [Abstract][Full Text] [Related]
11. Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux.
Wetscher GJ; Hinder RA; Smyrk T; Perdikis G; Adrian TE; Profanter C
Dig Dis Sci; 1999 Jun; 44(6):1132-5. PubMed ID: 10389684
[TBL] [Abstract][Full Text] [Related]
12. Acute pancreatitis associated with omeprazole.
Youssef SS; Iskandar SB; Scruggs J; Roy TM
Int J Clin Pharmacol Ther; 2005 Dec; 43(12):558-61. PubMed ID: 16372517
[TBL] [Abstract][Full Text] [Related]
13. Esomeprazole: a review of its use in the management of acid-related disorders.
Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
Drugs; 2002; 62(10):1503-38. PubMed ID: 12093317
[TBL] [Abstract][Full Text] [Related]
14. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
Cooper BT; Chapman W; Neumann CS; Gearty JC
Aliment Pharmacol Ther; 2006 Mar; 23(6):727-33. PubMed ID: 16556174
[TBL] [Abstract][Full Text] [Related]
15. Mortality in Barrett's oesophagus: results from a population based study.
Anderson LA; Murray LJ; Murphy SJ; Fitzpatrick DA; Johnston BT; Watson RG; McCarron P; Gavin AT
Gut; 2003 Aug; 52(8):1081-4. PubMed ID: 12865262
[TBL] [Abstract][Full Text] [Related]
16. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
17. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors.
Ortiz A; Martínez de Haro LF; Parrilla P; Molina J; Bermejo J; Munitiz V
Br J Surg; 1999 Nov; 86(11):1472-4. PubMed ID: 10583299
[TBL] [Abstract][Full Text] [Related]
18. Death from malignant disease after surgery for duodenal ulcer.
Macintyre IM; O'Brien F
Gut; 1994 Apr; 35(4):451-4. PubMed ID: 7695679
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease.
Armstrong D
Lancet; 2000 Aug; 356(9230):610-2. PubMed ID: 10968429
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
